PTBP1 and adrenal cortex carcinoma: Except for PRAD (p > 0.05), the survival time of patients with ACC, KIRP, LGG, LUAD, MESO, and SKCM was shorter when PTBP1 was highly expressed, with statistical significance (HR > 1, p ≤ 0.05) (Figure 4D).